ArticlePharmaceutics2024

Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood-Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent.

Emilio Rivera López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.